IntelliCyt Lands New Investor Funding to Aid in Expanding Global Commercial Efforts
IntelliCyt recently received investor funding that will enable the company to expand its commercial efforts globally and grow manufacturing capacity. In early June, the company reached an agreement to expand product sales to life science and pharmaceutical markets in China.
IntelliCyt is a life sciences technology company that develops, manufactures, sells and supports innovative high throughput flow cytometry products for life sciences research and drug discovery. These products, based on technology licensed from the University of New Mexico, allow customers to discover new and better ways to predict and treat disease.
IntelliCyt has received Job Training Incentive Program (JTIP) funding from the Economic Development Department to aid in the training of new workers.
View more Business Feature stories
Your browser does not support iframes.